CER Collaborative: Series of Questionnaires to Guide Decision-makers in Reviewing Studies

Published

Three peer-reviewed articles offer important guidance to aid formulary decision-makers in evaluating certain types of comparative effectiveness research (CER) studies. The articles, developed by CER Collaborative members Academy of Managed Care Pharmacy (AMCP), the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the National Pharmaceutical Council (NPC), and published in the March/April 2014 issue of Value in Health, describe how to assess the credibility and relevance of individual research studies for making coverage and reimbursement decisions.

Members of the CER Collaborative recognized that the growing availability of new research methods poses challenges and opportunities for today’s formulary decision-makers. There is little guidance on how to evaluate and use these new studies, creating a risk for two undesirable outcomes: new study data being misinterpreted or critical information not being used to inform decision-making.

To address those challenges, the CER Collaborative developed a series of questionnaires to guide decision-makers in reviewing studies, which are outlined in the following articles:

An online toolkit (www.cercollaborative.org) incorporating the three questionnaires also assists decision-makers as they assess and incorporate CER studies with other types of evidence for coverage and reimbursement decisions. The CER Collaborative also offers a Continuing Education Certificate, a 19-hour certificate program to guide pharmacists and other clinical decision-makers by advancing their expertise in assessing evidence and making use of the online CER Collaborative tool and resources.  

Watch the webinar below for more information about how to utilize the tools the CER Collaborative has developed: